Literature DB >> 24529727

Role of p-21-activated kinases in cancer progression.

Helen King1, Nicole S Nicholas1, Claire M Wells2.   

Abstract

The p-21-activated kinases (PAKs) are downstream effectors of Rho GTPases Rac and Cdc42. The PAK family consists of six members which are segregated into two subgroups (Group I and Group II) based on sequence homology. Group I PAKs (PAK1-3) are the most extensively studied but there is increasing interest in the functionality of Group II PAKs (PAK4-6). The PAK family proteins are thought to play an important role in many different cellular processes, some of which have particular significance in the context of cancer progression. This review explores established and more recent data, linking the PAK family kinases to cancer progression including expression profiles, evasion of apoptosis, promotion of cell survival, and regulation of cell invasion. Finally, we discuss attempts to therapeutically target the PAK family and outline the major obstacles that still need to be overcome.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Actin cytoskeleton; Apoptosis; Cell invasion; Cell survival; LIM kinase; Metastasis; p-21-activated kinase

Mesh:

Substances:

Year:  2014        PMID: 24529727     DOI: 10.1016/B978-0-12-800255-1.00007-7

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  40 in total

1.  PAK6 targets to cell-cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escape.

Authors:  Elizabeth M Morse; Xiaowen Sun; Jordan R Olberding; Byung Hak Ha; Titus J Boggon; David A Calderwood
Journal:  J Cell Sci       Date:  2015-11-23       Impact factor: 5.285

Review 2.  Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.

Authors:  Byung Hak Ha; Elizabeth M Morse; Benjamin E Turk; Titus J Boggon
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

3.  The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.

Authors:  Xiaowen Sun; Valerie L Su; David A Calderwood
Journal:  J Biol Chem       Date:  2019-08-07       Impact factor: 5.157

4.  Differential role for PAK1 and PAK4 during the invadopodia lifecycle.

Authors:  Nicole S Nicholas; Aikaterini Pipili; Michaela S Lesjak; Claire M Wells
Journal:  Small GTPases       Date:  2017-03-17

5.  P21-Activated Kinase 4 (PAK4) Inhibitors as Potential Cancer Therapy.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2014-11-06       Impact factor: 4.345

6.  PREX1 Protein Function Is Negatively Regulated Downstream of Receptor Tyrosine Kinase Activation by p21-activated Kinases (PAKs).

Authors:  Douglas Barrows; John Z He; Ramon Parsons
Journal:  J Biol Chem       Date:  2016-08-01       Impact factor: 5.157

7.  Group II p21-activated kinase, PAK4, is needed for activation of focal adhesion kinases, MAPK, GSK3, and β-catenin in rat pancreatic acinar cells.

Authors:  Irene Ramos-Álvarez; Lingaku Lee; Robert T Jensen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

8.  P21-activated kinase 4 in pancreatic acinar cells is activated by numerous gastrointestinal hormones/neurotransmitters and growth factors by novel signaling, and its activation stimulates secretory/growth cascades.

Authors:  Irene Ramos-Alvarez; R T Jensen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-04-19       Impact factor: 4.052

9.  Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia.

Authors:  S Takao; W Chien; V Madan; D-C Lin; L-W Ding; Q-Y Sun; A Mayakonda; M Sudo; L Xu; Y Chen; Y-Y Jiang; S Gery; M Lill; E Park; W Senapedis; E Baloglu; M Müschen; H P Koeffler
Journal:  Leukemia       Date:  2017-09-14       Impact factor: 11.528

10.  PAK4 crystal structures suggest unusual kinase conformational movements.

Authors:  Eric Y Zhang; Byung Hak Ha; Titus J Boggon
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-10-07       Impact factor: 3.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.